Vaxxas

Hamilton, Australia · Founded 2011 · Privately Held (backing)

Developer of a needle-free vaccine delivery system designed to enhance the performance of existing and next-generation vaccines. Vaxxas is based in Hamilton, Australia and was founded in 2011. Its last reported valuation was $236 million in Aug 2025. It has raised $154 million.

Last reported valuation

$235.6M

Oct 2026

Priced at

—

Total raised

$154.3M

Last round

—

How much has Vaxxas raised?

$154.3Macross 0 recorded rounds

Free account

More of Vaxxas with a free account

·The complete investor list: 22 names
·Watch Vaxxas: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Vaxxas investors

22 investors are on record for Vaxxas, including Gates Foundation, QIC, Wellcome Trust and Brandon Capital.

For fundraisers

Raising for a company like Vaxxas?

22 investors have backed Vaxxas.

See all 22 investors →

Frequently asked about Vaxxas

How much has Vaxxas raised?: Vaxxas has raised $154.3M in total across 0 recorded funding rounds.